3-aminobenzamide has been researched along with concanavalin a in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dennert, G; Landon, C; Nowicki, M; Sugawara, S | 1 |
Aupeix, K; Bischoff, P; Dufour, P; Marchal, J; Oth, D; Picard, V; Varin, M; Weltin, D | 1 |
Aeed, H; Avni, Y; Ben-Dror, I; Ben-Nachum, I; Bernadsky, O; Biro, A; Ernst, O; Fraser, IDC; Kandhikonda, R; Katz, D; Katz, S; Lilja, A; Wardi, J; Weinstain, R; Zor, T | 1 |
3 other study(ies) available for 3-aminobenzamide and concanavalin a
Article | Year |
---|---|
Nicotinamide and 3-aminobenzamide interfere with receptor-mediated transmembrane signaling in murine cytotoxic T cells: independence of Golgi reorientation from calcium mobilization and inositol phosphate generation.
Topics: Animals; Benzamides; Calcium; Concanavalin A; Cytotoxicity, Immunologic; Golgi Apparatus; Granzymes; Inositol Phosphates; Lymphocyte Culture Test, Mixed; Mice; Mice, Inbred Strains; Niacinamide; Phosphatidylinositols; Receptors, Antigen, T-Cell; Serine Endopeptidases; Signal Transduction; T-Lymphocytes, Cytotoxic | 1991 |
Immunosuppressive activities of 6(5H)-phenanthridinone, a new poly(ADP-ribose)polymerase inhibitor.
Topics: Acridines; Acridones; Animals; Benzamides; Cells, Cultured; Concanavalin A; Female; Gamma Rays; Immunosuppressive Agents; Interleukin-2; Isoquinolines; Killer Cells, Lymphokine-Activated; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Lymphocytes; Male; Mice; Mice, Inbred C3H; Mice, Inbred DBA; Phenanthrenes; Poly(ADP-ribose) Polymerase Inhibitors; Recombinant Proteins; Spleen; T-Lymphocytes, Cytotoxic | 1995 |
3-Aminobenzamide Prevents Concanavalin A-Induced Acute Hepatitis by an Anti-inflammatory and Anti-oxidative Mechanism.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Antioxidants; Benzamides; Cells, Cultured; Concanavalin A; Disease Models, Animal; Hepatitis; Macrophages; Mice; Mitogens; NF-kappa B; Nitric Oxide Synthase Type II; Poly(ADP-ribose) Polymerase Inhibitors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2018 |